Related Experiment Video
Updated: Jan 25, 2026

Assessing Agrochemical Risk to Mated Honey Bee Queens
Published on: March 3, 2021
Glioblastoma vs temozolomide: can the red queen race be won?
Anjali Arora1, Kumaravel Somasundaram1
1a Department of Microbiology and Cell Biology , Indian Institute of Science , Bangalore , India.
Abstract:
Glioblastoma is the most invasive form of brain tumor. Although temozolomide chemotherapy has been shown to significantly improve survival in patients with GBM, this increase is only trivial. The underlying cause is that many GBMs do not respond to temozolomide, and the rest produces resistance. In the past two decades, many attempts have been made to understand resistance mechanisms and to combine other treatments with temozolomide to maximize patient benefit. Unfortunately, it seems to be a red queen game, and the speed of disease development is as fast as the progress in the field. In order to win this game, a comprehensive approach is needed to decipher the details of the resistance mechanism and to transfer the basic research to the clinic. This article reviews the following: temozolomide discovery, chemistry, and mechanism of action, and mechanisms of resistance, as well as combination therapy with other strategies.
More Related Videos
09:40Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
Published on: October 4, 2019
11:48A Contrast of Three Inoculation Techniques used to Determine the Race of Unknown Fusarium oxysporum f.sp. niveum Isolates
Published on: October 28, 2021
Related Concept Videos
RACE - Rapid Amplification of cDNA Ends
Red Algae
Altruism
Social Scripts
Stereotypes, Prejudice, and Discrimination
Uncertainty in Measurement: Reading Instruments